News FAMHP

There are 2 result(s) found based on your search criteria

1-2 from 2 result(s)

European medicines authorities take further action in ongoing review of sartans

European medicines authorities have placed the Chinese company Zheijiang Huahai under increased supervision and the Indian company Aurobindo Pharma is no longer allowed to supply irbesartan to EU member states.

Update on review of certain recalled lots of valsartan medicines

The European Medicines Agency (EMA) is conducting a review of the possible health effects in patients who may have taken certain lots of valsartan medicines containing an impurity called NDMA. This impurity was found in the active substance manufactured by Zhejiang Huahai Pharmaceuticals.

1-2 from 2 result(s)